Sienna Biopharmaceuticals, Inc.·4

Jul 27, 4:27 PM ET

Stroehmann Diane 4

4 · Sienna Biopharmaceuticals, Inc. · Filed Jul 27, 2017

Insider Transaction Report

Form 4
Period: 2017-07-26
Stroehmann Diane
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-07-26+11,92611,926 total
    Exercise: $15.00Exp: 2027-07-26Common Stock (11,926 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from July 26, 2017, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4